About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

Guest Editorial: Is Cardio-oncology Ready for Algorithms?

Citation:

European Cardiology Review 2018;13(1):62–3.

Cardiovascular Implications of Sphingomyelin Presence in Biological Membranes

Citation:

European Cardiology Review 2018;13(1):42–5.

Guest Editorial: Reducing Risk in Familial Hypercholesterolaemia and Severe Dyslipidaemia: Novel Drugs Targeting PCSK9

Citation:

European Cardiology Review 2018;13(1):7–8.

Management of Severe Dyslipidaemia: Role of PCSK9 Inhibitors

Citation:

European Cardiology Review 2018;13(1):9–13.